Abstract |
The aim of the study described here was to evaluate the significance of the hepatic filling rate of a perflubutane microbubble agent in predicting long-term outcomes and prognoses in 32 patients with cirrhosis (37-76 y, 20 females, Child-Pugh A16, B16). The time from delivery of the contrast agent to the hepatic artery to maximum enhancement of the liver parenchyma on the sonogram was defined as the hepatic filling rate (mean = 18.6 s). Hepatic filling rate did not correlate significantly with the Child-Pugh score or the model for end-stage liver disease score. However, the survival rate was lower (93.3% at 1 y, 60.2% at 3 y) and the rate of occurrence of hepatocellular carcinoma (HCC) was higher (13.3% at 1 y, 33.3% at 3 y) in the group with the slow filling rate (≥18 s) than in the group with the rapid filling rate (<18 s) (93.3% at 1 and 3 y for survival, 6.3% at 1 and 3 y for HCC occurrence). Hepatic filling rate may constitute a non-invasive marker for the occurrence of HCC and prognosis of cirrhosis.
|
Authors | Tadashi Sekimoto, Hitoshi Maruyama, Soichiro Kiyono, Takayuki Kondo, Taro Shimada, Hiroyuki Ishibashi, Masanori Takahashi, Osamu Yokosuka, Tadashi Yamaguchi |
Journal | Ultrasound in medicine & biology
(Ultrasound Med Biol)
Vol. 40
Issue 9
Pg. 2082-8
(Sep 2014)
ISSN: 1879-291X [Electronic] England |
PMID | 25018029
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Contrast Media
- Fluorocarbons
- perfluorobutane
|
Topics |
- Adult
- Aged
- Contrast Media
(pharmacokinetics)
- Female
- Fluorocarbons
(pharmacokinetics)
- Follow-Up Studies
- Hepatic Artery
(diagnostic imaging)
- Humans
- Image Enhancement
(methods)
- Liver
(diagnostic imaging)
- Liver Cirrhosis
(diagnostic imaging, mortality, physiopathology)
- Male
- Microbubbles
- Middle Aged
- Prognosis
- Prospective Studies
- Risk Factors
- Severity of Illness Index
- Survival Rate
- Ultrasonography
|